CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. (Q34084006)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. |
scientific article |
Statements
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity (English)
Chen Y
DeWeese T
Dilley J
Zhang Y
Li Y
Ramesh N
Lee J
Pennathur-Das R
Radzyminski J
Wypych J
Brignetti D
Scott S
Stephens J
Karpf DB
Henderson DR